Stage FocusSeries B+
GeographyGlobal
TypeVC
Last Activity-
Industry Focus
Industries
Biotech
Technical BenchLimited
Investor TypeGeneralist
ExposureMinimal DeepTech Investments
Bio
Viking Global Investors manages more than $55 billion in assets, but it's fundamentally a hedge fund manager rather than a venture capital firm. The core business is long/short equity strategies across public markets, with multiple fund vehicles: Viking Global Equities (long/short), Viking Long (long-only), Viking Global Opportunities (public/private hybrid), Viking Structured Capital (credit), an...
Similar Funds
Covalent Ventures
Auckland, New Zealand
GeneralistBiotechFood TechMedtechSeedSeries A
Dale Ventures
Dubai, United Arab Emirates
GeneralistBiotechSeedSeries A
East West Capital
Sydney, Australia
GeneralistBiotechSeedSeries A
F-Prime Capital
Cambridge, Massachusetts, United States
GeneralistBiotechMedtechBlockchainSeedSeries A
Hummingbird VC
London, United Kingdom
GeneralistBiotechAIBlockchainPre-SeedSeed
Kylla Capital Partners
Amsterdam, Netherlands
GeneralistBiotechSeries B+